Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 10.29B |
| Enterprise Value | 10.4B |
| P/E Ratio | -449.92 |
| PEG Ratio | 3.2 |
| Price/Sales Ratio | 14.58 |
| Price/Book Ratio | 12.74 |
| Enterprise/Revenue | 14.96 |
| Enterprise/EBITDA | 124.69 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.03 |
| Operating Margin | 0.1 |
AD
Management Effectiveness
| Return On Assets | -0.01 |
| Return On Equity | -0.03 |
Income Statement
| Revenue | 704.16M |
| Revenue/Share | 1.87 |
| Gross Profit | 704.16M |
| EBITDA | 59.85M |
| Net Income | 22.23M |
| Diluted EPS | 0.05 |
Balance Sheet
| Total Cash | 235.28M |
| Total Cash/Share | 0.58 |
| Total Debt | 524.1M |
| Total Debt/Equity | 0.6 |
| Current Ratio | 1.29 |
| Book Value Per Share | 2.14 |
Price History
| 52-Week Change | -0.51 |
| 52-Week High | 44.9 |
| 52-Week Low | 20.41 |
| Moving Average 50 Days | 29.22 |
| Moving Average 200 Days | 29.95 |
Statistics
| Average Volume | 11.48M |
| Shares Outstanding | 405.41M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.53 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
